Key result
Antihypertensive therapy lowers systolic BP ~17 mmHg, improving ventricular-arterial coupling, cardiac work, and LV efficiency.
Why the study?
To investigate the effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency in early-stage hypertension.
Does antihypertensive therapy improve ventricular-arterial mechanics, coupling, and efficiency in adults with early-stage hypertension and diastolic dysfunction?
Cohort (n=527)
Yes
Does antihypertensive therapy improve ventricular-arterial mechanics, coupling, and efficiency in adults with early-stage hypertension and diastolic dysfunction?
p-value: p=< 0.001
Antihypertensive therapy improves ventricular-arterial coupling and LV efficiency in early-stage hypertension, with attenuated benefits observed in women and obese individuals.
May improve ventricular-arterial coupling in early hypertension; hypothesis-generating, requires randomized confirmation before practice change.
AIMS: To investigate the effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency in early-stage hypertension. METHODS AND RESULTS: We studied 527 participants from two clinical trials assessing the effect of blood pressure lowering on diastolic function. Participants were aged ≥45 years with early-stage hypertension, no heart failure, ejection fraction (EF) ≥50%, and diastolic dysfunction using Doppler echocardiography. Effective arterial afterload and its components were assessed along with measures of left ventricular (LV) structure and function prior to and after 24-38 weeks of antihypertensive therapy. Systolic blood pressure decreased from 154 ± 18 to 137 ± 15 mmHg at follow-up. Blood pressure reduction was associated with decreases in ventricular and arterial stiffness, improvements in systemic arterial compliance and resistance, enhanced LV ejection, and reduction in cardiac work (all P < 0.001). Changes in Ea/Ees ratio were inversely correlated with those in EF (r = -0.25; P < 0.001), stroke work index (r = -0.13; P = 0.007), and LV efficiency (r = -0.98; P < 0.001); and directly related to changes in mitral E/e' (r = 0.12; P = 0.01). Adjusting for age and blood pressure change, women and obese individuals had less enhancement in ventricular-arterial coupling and efficiency compared with men and non-obese individuals (P = 0.04 and 0.007, respectively). CONCLUSION: Antihypertensive therapy reduces arterial and ventricular stiffness, enhances ventricular-arterial coupling, reduces cardiac work, and improves LV efficiency, systolic, and diastolic function. Attenuated responses in women and among obese subjects suggest that structure-function changes may be less reversible in these groups, possibly explaining their greater susceptibility to ultimately develop heart failure.
No takes yet. Share an insight, caveat, or question.
Lam et al. (2012) conducted a cohort in early-stage hypertension (n=527). Antihypertensive therapy vs. Baseline (pre-therapy) was evaluated on ventricular and arterial stiffness, systemic arterial compliance and resistance, LV ejection, and cardiac work (p=< 0.001). Antihypertensive therapy decreased systolic blood pressure from 154 to 137 mmHg and significantly improved ventricular-arterial coupling, cardiac work, and LV efficiency (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: